ACE Inhibitors Are NOT First-Line for Isolated Systolic Hypertension
For isolated systolic hypertension with BP 207/66 mmHg, ACE inhibitors are not recommended as first-line monotherapy. Instead, initiate treatment with a thiazide/thiazide-like diuretic, long-acting dihydropyridine calcium channel blocker (CCB), or angiotensin receptor blocker (ARB) 1, 2, 3, 4.
Why ACE Inhibitors Are Not Preferred
Multiple Canadian Hypertension Education Program guidelines consistently exclude ACE inhibitors from first-line recommendations for isolated systolic hypertension 1, 2, 5, 3, 4. The evidence base supporting thiazide diuretics (Grade A), long-acting dihydropyridine CCBs (Grade A), and ARBs (Grade B) is substantially stronger for this specific presentation 2, 3.
ACE inhibitors may be added as second-line or combination therapy if BP targets are not achieved with standard-dose monotherapy of the preferred agents 1, 2, 3.
Recommended Treatment Algorithm
Step 1: Initial Monotherapy
Choose ONE of the following:
- Thiazide/thiazide-like diuretic (hydrochlorothiazide, chlorthalidone, or indapamide) - Grade A evidence 2, 3
- Long-acting dihydropyridine CCB (amlodipine, nifedipine extended-release) - Grade A evidence 2, 3
- ARB (losartan, valsartan, telmisartan) - Grade B evidence 2, 3
Critical caveat: Avoid hypokalemia if using thiazide monotherapy (Grade C) 2, 3.
Step 2: If BP Not Controlled
Add a second agent from the first-line options above (Grade B) 2, 3. At this stage, ACE inhibitors can be incorporated into combination therapy:
- Thiazide/thiazide-like diuretic + ACE inhibitor (Grade D) 2
- Dihydropyridine CCB + ACE inhibitor (Grade A for general hypertension, Grade C-D for isolated systolic) 2, 3
Step 3: Resistant Hypertension
If BP remains uncontrolled with two first-line agents, escalate to three-drug combination, typically:
- RAS blocker (ACE inhibitor or ARB) + dihydropyridine CCB + thiazide/thiazide-like diuretic 2
Never combine ACE inhibitor + ARB (Grade A contraindication) 2, 3.
Special Considerations for This Patient
With BP 207/66 mmHg, this patient has:
- Severely elevated systolic BP (>160 mmHg above target)
- Wide pulse pressure (141 mmHg), suggesting significant arterial stiffness
- Normal-to-low diastolic BP (66 mmHg)
Immediate Concerns:
- Caution with diastolic BP lowering: When treating isolated systolic hypertension with low diastolic BP (<70 mmHg), be cautious about excessive diastolic reduction, particularly if coronary artery disease is present, as myocardial ischemia may be exacerbated 3.
- Consider combination therapy from the start: Given SBP is >20 mmHg above target (assuming target <140 mmHg), combination therapy may be initiated (Grade C), though exercise caution in elderly or frail patients 2, 3.
If ACE Inhibitors Are Eventually Used:
Research suggests ACE inhibitor-diuretic combinations produce greater reductions in systolic ambulatory BP (particularly nocturnal) and arterial stiffness compared to CCB or diuretic monotherapy in isolated systolic hypertension 6. However, this applies to combination therapy, not monotherapy.
Age-Specific Targets
- Age <80 years: Target SBP <140 mmHg 2
- Age ≥80 years: Target SBP <150 mmHg (Grade C) 1
- All ages: Target DBP <90 mmHg 2
The 2024 ESC guidelines suggest targeting SBP 120-129 mmHg if well-tolerated 7, though Canadian guidelines remain more conservative.
Common Pitfalls to Avoid
- Do not start with ACE inhibitor monotherapy for isolated systolic hypertension - this lacks Grade A evidence and is not guideline-recommended
- Do not combine ACE inhibitor + ARB - associated with harm without additional benefit 2
- Do not use beta-blockers as first-line in patients ≥60 years with isolated systolic hypertension (Grade A) 2, 3
- Monitor for excessive diastolic BP reduction given baseline of 66 mmHg
- Avoid rapid BP reduction - titrate gradually, especially if elderly or frail